BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6296002)

  • 1. Ceftizoxime in the treatment of infections in patients with cancer.
    Fainstein V; Bolivar R; Elting L; Valdivieso M; Bodey GP
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():167-73. PubMed ID: 6296002
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftizoxime treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Baskin RC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():159-65. PubMed ID: 6296001
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftizoxime in moderate-to-severe infections.
    Johnson ES; Smith LG
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():151-7. PubMed ID: 6296000
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
    Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
    Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftizoxime plus ticarcillin: double beta-lactam therapy for infections in cancer patients.
    Rolston KV; Jones PG; Fainstein V; Elting L; Bodey GP
    J Antimicrob Chemother; 1987 Mar; 19(3):367-71. PubMed ID: 3471752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
    Yangco BG; Baird I; Lorber B; Noble R; Bermudez R; Silverblatt F; Vasquez G
    J Antimicrob Chemother; 1987 Feb; 19(2):239-48. PubMed ID: 3553135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ceftizoxime in the treatment of paediatric infections.
    Shikuma CM; Cable DC; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():293-5. PubMed ID: 6296023
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of ceftizoxime in the treatment of critically ill patients infected with multiply antibiotic resistant bacteria.
    Scully BE; Neu HC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():141-50. PubMed ID: 6295999
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of ceftizoxime and related compounds in animals models of infection.
    Actor P; Grappel SF
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():81-9. PubMed ID: 6296033
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with ceftizoxime: an overall summary of clinical trials in Japan.
    Shimada J; Shimizu K
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():311-26. PubMed ID: 6296026
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of ceftizoxime in acute peritonitis.
    Lou MA; Chen DF; Bansal M; Balasubramaniam S; Thadepalli H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():183-9. PubMed ID: 6296004
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceftizoxime treatment of pneumonia, cellulitis and other infections in 120 hospitalized patients.
    Counts GW; Hill CD; Hooton TM; Turck M
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():201-7. PubMed ID: 6296007
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of ceftizoxime in the therapy of bacteraemia.
    Bechard DL
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():175-81. PubMed ID: 6296003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of cefuzonam (CZON) with cefotiam in bacterial pneumonia and pulmonary suppuration].
    Soejima R; Matsushima T; Niki Y; Kawane H; Kawanishi M; Watanabe M; Hino J; Nakagawa Y; Umeki S; Sumi M
    Kansenshogaku Zasshi; 1986 Aug; 60(8):885-910. PubMed ID: 3098872
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effects of ceftizoxime and latamoxef on infections in acute leukemia].
    Kohi F; Ohmoto E; Endo Y; Oda Y; Fujimoto S; Uchida K; Takaoka K; Hara M; Lai M; Takahashi I
    Jpn J Antibiot; 1983 Jul; 36(7):1645-52. PubMed ID: 6317909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftizoxime: clinical evaluation of efficacy and safety in the U.S.A.
    Parks D; Layne P; Uri J; Ziv D; Bass S
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():327-38. PubMed ID: 6296027
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-blind controlled study of ceftizoxime and cefamandole in the treatment of community-acquired pneumonia.
    Grieco MM; Lange M; Daniels JA; Den M; Amaram N; Kornfeld H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():223-5. PubMed ID: 6296010
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical effect of ceftizoxime suppositories].
    Kuramitsu M; Morioka N; Morita H; Wakiguchi H; Ogura H; Kurashige T; Kitamura I
    Jpn J Antibiot; 1985 Oct; 38(10):2962-9. PubMed ID: 2934562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
    Mills J; Slutkin G; Klein D; Schecter W
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():273-9. PubMed ID: 6296020
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.
    LeFrock JL; Molavi A; Lentnek AL; Rolston KV; Chandrasekar PH; Smith BR; Kannangara W; Schell RF; Oaks SS; Carr BB
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():215-21. PubMed ID: 6296009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.